Rova, Cherokee R. L., M.S., Autumn 2006 Pharmaceutical Sciences Adeno-associated virus mediated transduction of sensory epithelia within the guinea pig cochlea Chairperson: Dr. David J. Poulsen, PhD. Hearing loss is the most common disability of the senses and affects 250 million people worldwide. This condition is often caused by the degeneration of the sensory cells, called hair cells, found within the cochlea. Hair cell damage can result from factors such as disease, ototoxic insult, excessive noise and age. Because treatments for hearing loss are limited, scientists are looking to the use of transgene expression as a means of regenerating hair cells from nearby support cells. One possible means of transgene delivery is adeno-associate...
Efforts to develop gene therapies for hearing loss have been hampered by the lack of safe, efficient...
International audienceCongenital deafness, affecting 1 in 1000 neonates, can lead to major problems ...
Viral delivery of exogenous coding sequences into the inner ear has the potential for therapeutic be...
Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and di...
<div><p>The degeneration of hair cells in the mammalian cochlea results in permanent sensorineural h...
The aims of this study were to evaluate the expression of enhanced green fluorescent protein (EGFP) ...
The aims of this study were to evaluate the expression of enhanced green fluorescent protein (EGFP) ...
Mammalian inner ear harbors diverse cell types that are essential for hearing and balance. Adenoviru...
Sensorineural hearing loss is one of the most common disabilities worldwide. Such prevalence necessi...
Targeting specific cell types in the mammalian inner ear is important for treating genetic hearing l...
Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and di...
Adeno-associated virus (AAV) is a safe and effective vector for gene therapy for retinal disorders. ...
Cochlear gene therapy can be a new avenue for the treatment of severe hearing loss by inducing regen...
Gene delivery is a key component for the treatment of genetic hearing loss. To date, a myriad of ade...
AbstractObjectiveTo study expression of adenoviral–mediated Hath1–EGFP gene in the guinea pig cochle...
Efforts to develop gene therapies for hearing loss have been hampered by the lack of safe, efficient...
International audienceCongenital deafness, affecting 1 in 1000 neonates, can lead to major problems ...
Viral delivery of exogenous coding sequences into the inner ear has the potential for therapeutic be...
Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and di...
<div><p>The degeneration of hair cells in the mammalian cochlea results in permanent sensorineural h...
The aims of this study were to evaluate the expression of enhanced green fluorescent protein (EGFP) ...
The aims of this study were to evaluate the expression of enhanced green fluorescent protein (EGFP) ...
Mammalian inner ear harbors diverse cell types that are essential for hearing and balance. Adenoviru...
Sensorineural hearing loss is one of the most common disabilities worldwide. Such prevalence necessi...
Targeting specific cell types in the mammalian inner ear is important for treating genetic hearing l...
Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and di...
Adeno-associated virus (AAV) is a safe and effective vector for gene therapy for retinal disorders. ...
Cochlear gene therapy can be a new avenue for the treatment of severe hearing loss by inducing regen...
Gene delivery is a key component for the treatment of genetic hearing loss. To date, a myriad of ade...
AbstractObjectiveTo study expression of adenoviral–mediated Hath1–EGFP gene in the guinea pig cochle...
Efforts to develop gene therapies for hearing loss have been hampered by the lack of safe, efficient...
International audienceCongenital deafness, affecting 1 in 1000 neonates, can lead to major problems ...
Viral delivery of exogenous coding sequences into the inner ear has the potential for therapeutic be...